Supplemental findings of the 2023 National Blood Collection and Utilization Survey.

IF 2 3区 医学 Q2 HEMATOLOGY
Transfusion Pub Date : 2025-08-01 DOI:10.1111/trf.18336
Isabel S Griffin, Ian Kracalik, Kelsey McDavid, Tatiana Bradley, Joel Chavez Ortiz, James J Berger, Sridhar V Basavaraju, Rebecca Lien
{"title":"Supplemental findings of the 2023 National Blood Collection and Utilization Survey.","authors":"Isabel S Griffin, Ian Kracalik, Kelsey McDavid, Tatiana Bradley, Joel Chavez Ortiz, James J Berger, Sridhar V Basavaraju, Rebecca Lien","doi":"10.1111/trf.18336","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The National Blood Collection and Utilization Survey (NBCUS) is conducted biennially to estimate US blood collection and utilization. Supplemental data from the 2023 NBCUS not presented elsewhere are described here.</p><p><strong>Methods: </strong>Data on blood donor characteristics, donation deferrals, component costs, transfusion-associated adverse reactions, and use of pathogen-reduced platelets during 2023 were collected from US blood collecting and transfusing facilities. National estimates were produced using weighting and imputation methods.</p><p><strong>Results: </strong>Compared with 2021, successful blood donations from donors aged 45-64 decreased (11%) in 2023 but still accounted for most donations overall (39%). Donations from donors aged 16-18 years, Black or African American, and Hispanic donors increased by 66%, 38%, and 9%, respectively, since 2021. Donation deferrals for travel increased since 2021 (+162%). From 2021 to 2023, the median price hospitals paid per unit of leukoreduced red blood cells, fresh frozen plasma, and leukoreduced and pathogen-reduced apheresis platelets increased. Apheresis platelets experienced the largest price increase per unit (+$65). Compared with 2021, the proportion of transfusing facilities using pathogen-reduced platelets increased in 2023 (60% vs. 64%). The overall rate of transfusion-associated adverse reactions per 100,000 components transfused was higher in 2023 than in 2021 (312.3 vs. 273.8), although the rate of transfusion-transmitted infections (bacterial, viral, and parasitic) declined in 2023 (0.25 vs. 0.43).</p><p><strong>Conclusion: </strong>From 2021 to 2023, blood donations among older donors decreased, while donations from younger and Black or African American donors increased. Adoption of pathogen-reduced platelets and cost of all blood products increased.</p>","PeriodicalId":23266,"journal":{"name":"Transfusion","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12477558/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/trf.18336","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The National Blood Collection and Utilization Survey (NBCUS) is conducted biennially to estimate US blood collection and utilization. Supplemental data from the 2023 NBCUS not presented elsewhere are described here.

Methods: Data on blood donor characteristics, donation deferrals, component costs, transfusion-associated adverse reactions, and use of pathogen-reduced platelets during 2023 were collected from US blood collecting and transfusing facilities. National estimates were produced using weighting and imputation methods.

Results: Compared with 2021, successful blood donations from donors aged 45-64 decreased (11%) in 2023 but still accounted for most donations overall (39%). Donations from donors aged 16-18 years, Black or African American, and Hispanic donors increased by 66%, 38%, and 9%, respectively, since 2021. Donation deferrals for travel increased since 2021 (+162%). From 2021 to 2023, the median price hospitals paid per unit of leukoreduced red blood cells, fresh frozen plasma, and leukoreduced and pathogen-reduced apheresis platelets increased. Apheresis platelets experienced the largest price increase per unit (+$65). Compared with 2021, the proportion of transfusing facilities using pathogen-reduced platelets increased in 2023 (60% vs. 64%). The overall rate of transfusion-associated adverse reactions per 100,000 components transfused was higher in 2023 than in 2021 (312.3 vs. 273.8), although the rate of transfusion-transmitted infections (bacterial, viral, and parasitic) declined in 2023 (0.25 vs. 0.43).

Conclusion: From 2021 to 2023, blood donations among older donors decreased, while donations from younger and Black or African American donors increased. Adoption of pathogen-reduced platelets and cost of all blood products increased.

2023年全国血液采集和利用调查的补充结果。
背景:国家血液采集和利用调查(NBCUS)每两年进行一次,以估计美国的血液采集和利用情况。本文描述了其他地方未提供的2023年NBCUS的补充数据。方法:从美国采血和输血设施收集2023年期间献血者特征、延迟献血、成分成本、输血相关不良反应和病原体减少血小板使用的数据。使用加权和估算方法得出了国家估计数。结果:与2021年相比,2023年45-64岁献血者献血成功率下降(11%),但仍占献血者总数的39%。自2021年以来,16-18岁捐赠者、黑人或非裔美国人和西班牙裔捐赠者的捐款分别增长了66%、38%和9%。自2021年以来,旅行捐款延期增加(+162%)。从2021年到2023年,医院支付的单位白化红细胞、新鲜冷冻血浆、白化血小板和减少病原体的单采血小板的中位数价格上升。单采血小板的单位价格涨幅最大(+ 65美元)。与2021年相比,2023年使用病原体减少的血小板的输血设施比例增加(60%对64%)。2023年输血相关不良反应的总体发生率高于2021年(312.3比273.8),尽管输血传播感染率(细菌、病毒和寄生虫)在2023年有所下降(0.25比0.43)。结论:从2021年到2023年,老年献血者的献血量下降,而年轻献血者和黑人或非裔美国人的献血量增加。采用减少病原体的血小板和所有血液制品的成本增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Transfusion
Transfusion 医学-血液学
CiteScore
4.70
自引率
20.70%
发文量
426
审稿时长
1 months
期刊介绍: TRANSFUSION is the foremost publication in the world for new information regarding transfusion medicine. Written by and for members of AABB and other health-care workers, TRANSFUSION reports on the latest technical advances, discusses opposing viewpoints regarding controversial issues, and presents key conference proceedings. In addition to blood banking and transfusion medicine topics, TRANSFUSION presents submissions concerning patient blood management, tissue transplantation and hematopoietic, cellular, and gene therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信